Fibroblast growth factor-23 and cardiovascular events in CKD

An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abnormality of mineral metabolism in CKD. High FGF-23 levels promote left ventricular hypertrophy but not coronary artery calcification. We used survival analysis to determine whether elevated FGF-23 is associated with greater...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American Society of Nephrology Ročník 25; číslo 2; s. 349
Hlavní autoři:	Scialla, Julia J, Xie, Huiliang, Rahman, Mahboob, Anderson, Amanda Hyre, Isakova, Tamara, Ojo, Akinlolu, Zhang, Xiaoming, Nessel, Lisa, Hamano, Takayuki, Grunwald, Juan E, Raj, Dominic S, Yang, Wei, He, Jiang, Lash, James P, Go, Alan S, Kusek, John W, Feldman, Harold, Wolf, Myles
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.02.2014
Témata:	Aged Atherosclerosis - blood Atherosclerosis - epidemiology Biomarkers Cardiovascular Diseases - blood Cardiovascular Diseases - epidemiology Comorbidity Female Fibroblast Growth Factors - blood Follow-Up Studies Heart Failure - blood Heart Failure - epidemiology Hospitalization - statistics & numerical data Humans Incidence Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - etiology Male Middle Aged Models, Biological Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - epidemiology Risk Risk Factors Sensitivity and Specificity
ISSN:	1533-3450, 1533-3450
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!